Actively Recruiting
Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World
Led by West China Hospital · Updated on 2025-08-06
300
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Chidamide + sintilimab ± bevacizumab regimen has become a post-treatment option for clinicians and patients after being included in the guidelines. The CAPability-01 study is a phase II RCT, with a limited number of enrolled subjects. Further observation of the safety and clinical real-world application status of the sidibemab combination regimen is needed in a larger sample size prospective observational cohort study. The primary endpoint of this study is the safety events of the sidibemab combination regimen.
CONDITIONS
Official Title
Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Advanced colorectal cancer confirmed by tissue testing
- Cancer confirmed as MSS or pMMR type by immunohistochemistry or genetic testing
- Investigator deems cediranib combined with immune checkpoint inhibitors treatment suitable
- Clear consciousness and ability to answer questions correctly
- Ability to use mobile phones with internet access (3G/4G/5G)
You will not qualify if you...
- Serious complications interfering with safety and efficacy analysis
- Investigator determines subject is unsuitable for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital Sichuan University
Chengdu, Sichuan, China, 827153
Actively Recruiting
Research Team
M
meng Qiu PhD West China Hospital of Sichuan university
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here